Vanguard Group’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $7.57K | Sell |
|
|||||
|
2024
Q4 | $75.3K | Sell |
|
|||||
|
2024
Q3 | $449K | Hold |
|
|||||
|
2024
Q2 | $508K | Sell |
|
|||||
|
2024
Q1 | $3.37M | Buy |
|
|||||
|
2023
Q4 | $606K | Hold |
|
|||||
|
2023
Q3 | $519K | Sell |
|
|||||
|
2023
Q2 | $676K | Hold |
|
|||||
|
2023
Q1 | $541K | Hold |
|
|||||
|
2022
Q4 | $531K | Sell |
|
|||||
|
2022
Q3 | $720K | Sell |
|
|||||
|
2022
Q2 | $765K | Sell |
|
|||||
|
2022
Q1 | $2.66M | Buy |
|
|||||
|
2021
Q4 | $6.67M | Buy |
|
|||||
|
2021
Q3 | $8.65M | Buy |
|
|||||
|
2021
Q2 | $6.24M | Buy |
|
|||||
|
2021
Q1 | $7.53M | Buy |
|